[3+2] versus [4+2] cycloadditions of quinone monoimide with azadienes: A Lewis acid-free access to 5-amino-2,3-dihydrobenzofuranes

Organic Letters

Volumn 8, Issue 18, 2006, Pages 3919-3922

  Lomberget, Thierry ^a   Baragona, Fabien ^a   Fenet, Bernard ^a   Barret, Roland ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748949232     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol061184a     Document Type: Article

References (33)

1. For a recent and exhaustive review on the chemistry of quinone imides, see: Nair, V.; Dhanya, R.; Rajesh, C.; Devipriya, S. Synlett 2005, 2407.
2. (a) Engler, T. A.; Chai, W.; Lynch, K. O. Tetrahedron Lett. 1995, 36, 7003.
3. (b) Engler, T. A.; Chai, W.; LaTessa, K. O. J. Org. Chem. 1996, 61, 9297.
4. England, D. B.; Kerr, M. A. J. Org. Chem. 2005, 70, 6519.
5. For examples of the synthetic utility of α,β-unsaturated N,N-dimethylhydrazones for the elaboration of nitrogen heterocycles, see: (a) Serckx-Poncin, B.; Hesbain-Frisque, A.-M.; Ghosez, L. Tetrahedron Lett. 1982, 23, 3261.
6. (b) Waldner, A. Helv. Chim. Acta 1988, 71, 486.
7. (c) For a review: Pautet, F.; Nebois, P.; Bouaziz, Z.; Pillion, H. Heterocycles 2001, 54, 1095.
8. This strategy has been exploited in the quinone series for the preparation of various heterocycles: (a) Kitahara, Y.; Tamura, F.; Nishimura, M.; Kubo, A. Tetrahedron 1998, 54, 8421.
9. (b) Pascual-Alfonso, E.; Avendaño, C.; Menéndez, J. C. Synlett 2000, 205.
10. (c) Alvarez, F.; Taleb, A.; Gentili, J.; Nebois, P.; Terreux, R.; Domard, M.; Thozet, A.; Merle, D.; Fillion, H.; Walchshofer, N. Eur. J. Org. Chem. 2005, 1903.
11. Adams, R.; Looker, J. H. J. Am. Chem. Soc. 1951, 73, 1145.
12. 3) to proceed in a 38% yield (20 h reaction time, 23 °C): Echavarren, A. M. J. Org. Chem. 1990, 55, 4255.
13. For an optimized synthesis of compound 5 involving its selective precipitation, see Supporting Information.
14. 3 generally contains acid traces which behave as a catalyst for the transformation of the keto compound 5 into the phenol 7.
15. 1H NMR after a 22 h stay at 25 °C.
16. 2 nitrogen is 2.21 Å (measured on the X-ray crystal structure).
17. Blanco, M. M.; Alonso, M. A.; Avendaño, C.; Menéndez, J. C. Tetrahedron 1996, 52, 5933.
18. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 3rd ed.; Wiley-Interscience: New York, 1999.
19. 15N NMR spectroscopy at the natural abundance: Martin, G. E.; Hadden, C. E. J. Nat. Prod. 2000, 63, 543.
20. Ämmälahti, E.; Bardet, M.; Molko, D.; Cadet, J. J. Magn. Res., Ser. A 1996, 122, 230.
21. For some examples: (a) anti-HIV pterocarpans: Engler, T. A.; LaTessa, K. O.; Iyengar, R.; Chai, W.: Agrios, K. Bioorg. Med. Chem. 1996, 4, 1755.
22. (b) Antihypertensive Efaroxan: de Carvalho e Silveira, G. P.; Coelho, F. Tetrahedron Lett. 2005, 46, 6477 and references therein.
23. (c) Melatoninergic agents: Sun, L.-Q.; Takaki, K.; Chen, J.; Bertenshaw, S.; Iben, L.; Mahle, C. D.; Ryan, E.; Wu, D.; Gao, Q.; Xu, C. Bioorg. Med. Chem. Lett. 2005, 25, 1345.
24. (d) PPARα agonists: Shi, G. Q.; Dropinski, J. F.; Zhang, Y.; Santini, C.; Sahoo, S. P.; Berger, J. P.; MacNaul, K. L.; Zhou, G.; Agrawal, A.; Alvaro, R.; Cai, T.-q.; Hernandez, M.; Wright, S. D.; Moller, D. E.; Heck, J. V.; Meinke, P. T. J. Med. Chem. 2005, 48, 5589.
25. (e) κ-opioid agonists: Chu, G.-H.; Gu, M.; Cassel, J. A.; Belanger, S.; Graczyk, T. M.; DeHaven, R. N.; Conway J.; Koblish, M.; Little, P. J.; Dehaven-Hudkins, D. L.; Dolle, R. E. Bioorg. Med. Chem. 2005, 15, 5114.
26. For recent reports on the preparation of dihydrobenzofuranes, see: (a) Saito, H.; Oishi, H.; Kitagaki, S.; Nakamura, S.; Anada, M.; Hashimoto, S. Org. Lett. 2002, 4, 3887.
27. (b) Barluenga, J.; Fañanás, F. J.; Sanz, R.; Marcos, C. Chem.-Eur. J. 2005, 11, 5397.
28. (c) Trend, R. M.; Ramtohul, Y. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 17778.
29. (d) Grant, V. H.; Liu, B. Tetrahedron Lett. 2005, 46, 1237.
30. (e) Lin, H.; Schall, A.; Reiser, O. Synlett 2005, 2603.
31. The use of a 2-fold excess of 1a led to a more complex reaction mixture: this could be explained by the oxidizing properties of the quinoid compound 1a.
32. 2 = H) led to a complex mixture with only traces of the corresponding DHBF.
33. For a review on the construction of enantioenriched quaternary stereocenters, see: Trost, B. M.; Jiang, C. Synthesis 2006, 369.